Tirzepatide-Bioverse : r/TirzepatideRX
US$ 27.08
gip/glp-1 agonist New strategies for the treatment of obesity and metabolic dysfunctions Frontiers | Clinical perspectives on
Description
This work is published and licensed by Dove Medical Press Limited
In summary, there are evidence, that treatment with GLP-1RAs may prove useful in the treatment of depressive disorders, however, the number of reliable clinical reports concerning this matter remains very low at this point
[PubMed] [Google Scholar] 7.Obesity: identification, assessment and management Clinical guideline
Participants were randomly assigned to groups either receiving a once-per-week subcutaneous injection of tirzepatide(5 mg, 10 mg, or 15 mg) or insulin glargine (100 U/mL)
doi: 10.1002/cphy.c190007 50 YuJZhangYZhuYCLiYSLinSYLiuWet al
